Microchip Technology (MCHP) has launched the dsPIC33CK Value Line digital signal controllers, targeting cost-sensitive real-time control applications. These new devices offer essential performance such as 100 MHz processing and high-resolution PWM, starting at $0.51 with consistent pricing regardless of order volume. They are designed to simplify system design and reduce costs in industrial, automotive, consumer, and medical applications.

Macy's Inc (M) shares rose 6.7% to $22.45, with a 95.7% increase over the past year. However, GuruFocus's GF Value indicates that the stock is significantly overvalued at 47.8% above its estimated fair value of $15.19. The company has a GF Score of 73/100, reflecting above-average quality, but insiders have sold $2.9 million worth of stock recently with no buying activity, raising concerns about its current valuation and growth prospects.

Microchip Technology Inc. has launched its dsPIC33CK Value Line family of Digital Signal Controllers (DSCs) designed for cost-sensitive real-time control applications. These DSCs offer deterministic processing, high-resolution PWM, and a 12-bit ADC, enabling applications like motor FOC and precision sensing without unnecessary features. The Value Line DSCs provide consistent pricing across all purchase volumes and boast automotive-grade reliability, simplifying design and production planning for various industries.

Dollar General shareholders are set to vote on a board-level human rights policy amidst pressure from institutional and faith-based investors. Concurrently, the company has announced a CEO succession plan targeting a leadership transition in 2027. These developments place Dollar General's governance, risk management, and operational continuity under increased scrutiny for investors, as the stock has shown mixed performance recently.

Chinese biopharmaceutical firm Innovent Biologics and U.S. pharma giant Pfizer have formed a global licensing and collaboration deal worth up to $10.5 billion to develop 12 early-stage cancer medicines. The agreement includes an upfront payment of $650 million to Innovent and up to $9.85 billion in potential milestone payments. The partnership encompasses a portfolio of antibody-drug conjugates and multi-specific antibodies, with varying development and commercialization rights across different programs and regions.

Arista Networks CFO Chantelle Yvette Breithaupt sold 2,448 shares of the company's common stock for $384,336 on May 26, 2026, pursuant to a pre-established trading plan. Following the sale, she directly owns 64,408 shares. Despite a strong 67% gain over the past year, InvestingPro analysis suggests the stock is currently overvalued, with a P/E ratio of 53.09.

Andreas Bechtolsheim, a 10% owner of Arista Networks (NYSE:ANET), sold approximately $34.5 million worth of common stock on May 26, 2026, through a Rule 10b5-1 trading plan. The sales involved 210,000 shares at prices ranging from $154.4979 to $160.0051 per share, held indirectly by a family trust. Despite a 67% return over the past year, InvestingPro analysis suggests the stock is currently overvalued, yet analysts like TD Cowen and Piper Sandler have recently raised their price targets for Arista Networks following strong Q1 2026 earnings.

Danaher Corp. shares traded near recent highs after the company raised its full-year adjusted EPS outlook following its Q1 2026 results. The stock, trading at approximately $180.63 with a market capitalization of $127.8 billion and a P/E ratio of about 33.5, saw active discussion regarding its valuation and growth prospects. This performance and investor interest are largely attributed to strong core revenue growth, particularly in Biotechnology and Life Sciences segments, and continued investment in advanced technologies like digital pathology.

Packaging Corporation of America's CEO, Mark Kowlzan, sold 9,266 shares of PKG stock for approximately $2.0 million, reducing his stake by 1.92% but still holding over 473,000 shares. The company recently increased its quarterly dividend to $1.50 per share, resulting in a 2.8% yield, and reported better-than-expected earnings of $2.40 per share for the last quarter. Analysts currently rate PKG as a "Moderate Buy" with an average price target of $236.57.

United Airlines' EVP Kate Gebo sold shares totaling over $3.65 million in two separate transactions on May 26th, decreasing her direct ownership by 33.86%. Despite this insider selling, UAL stock traded up 2.2% to $115.06, nearing its 52-week high, following better-than-expected earnings and upbeat guidance. The company maintains a "Moderate Buy" consensus rating from Wall Street analysts.